Author Search Results for "Zhao Fang"

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2024 Pg. 364-372	Crushability Analysis of Immediate-Release Oral Tablets and Capsules from the 2020-22 FDA Novel Drug Approvals Author(s): Saei Kamaladdin, Schweighardt Anne, Zhao Fang
Jan/Feb 2024 Pg. 82-86	Extemporaneous Compounding of Low-strength Aspirin Capsules for Desensitization Protocols Author(s): Messenger Carly, Soper Bailey, Cutaia Kara, Zhao Fang
Sep/Oct 2021 Pg. 364-371	Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products Author(s): Uttaro Elizabeth, Zhao Fang, Schweighardt Anne
Jan/Feb 2021 Pg. 82-87	Physical-chemical Stability of Compounded Sildenafil 100-mg Rapid-dissolving Tablets Author(s): Cheung Matthew, Zhao Fang, Dave Vivek S
May/Jun 2019 Pg. 258-263	An Exploratory Study of Suboxone (Buprenorphine/Naloxone) Film Splitting: Cutting Methods, Content Uniformity, and Stability Author(s): Reindel Kristin L, DeAngelis Michael J, Ferrara Alexander S, Conn Kelly M, Phillips Elizabeth M, Corigliano Anthony T, Zhao Fang
Nov/Dec 2018 Pg. 480-489	Basics of Compounding: Vehicles for Compounded Oral Liquid Medications: A Review Author(s): Cutaia Kara, Chablani Lipika, Zhao Fang
Sep/Oct 2018 Pg. 433-439	Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding Author(s): Zhao Fang, Dave Vivek S, Mar Mazin Z, Perri Jonathan R
Jan/Feb 2017 Pg. 83-87	A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding Author(s): Rush Steven D, Vernak Charlene, Zhao Fang